Kymera Therapeutics, Inc.KYMRNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 34 | 73↑114.0% | 47↓35.7% | 79↑67.8% | 47↓40.1% |
| Gross Profit | 34 | 73↑114.0% | 47↓35.7% | 79↑67.8% | 47↓40.1% |
| Operating Income | -46 | -101↓117.1% | -161↓60.4% | -166↓2.7% | -262↓58.1% |
| Net Income | -46 | -100↓119.8% | -155↓54.5% | -147↑5.1% | -224↓52.3% |
| EBITDA | -44 | -98↓123.4% | -152↓55.3% | -143↑5.6% | -216↓51.0% |
| EPS Diluted | -0.99 | -2.09↓111.1% | -2.87↓37.3% | -2.52↑12.2% | -2.98↓18.3% |